- Home
- BASE vs HUMA Comparison
BASE vs HUMA Comparison
Compare BASE & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BASE
- HUMA
- Stock Information
- Founded
- BASE 2011
- HUMA 2004
- Country
- BASE United States
- HUMA United States
- Employees
- BASE N/A
- HUMA N/A
- Industry
- BASE EDP Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- BASE Technology
- HUMA Health Care
- Exchange
- BASE Nasdaq
- HUMA Nasdaq
- Market Cap
- BASE 834.0M
- HUMA 691.8M
- IPO Year
- BASE 2021
- HUMA N/A
- Fundamental
- Price
- BASE $19.25
- HUMA $4.84
- Analyst Decision
- BASE Buy
- HUMA Strong Buy
- Analyst Count
- BASE 13
- HUMA 7
- Target Price
- BASE $23.31
- HUMA $12.71
- AVG Volume (30 Days)
- BASE 261.2K
- HUMA 3.2M
- Earning Date
- BASE 12-03-2024
- HUMA 11-08-2024
- Dividend Yield
- BASE N/A
- HUMA N/A
- EPS Growth
- BASE N/A
- HUMA N/A
- EPS
- BASE N/A
- HUMA N/A
- Revenue
- BASE $198,818,000.00
- HUMA N/A
- Revenue This Year
- BASE $17.65
- HUMA N/A
- Revenue Next Year
- BASE $15.17
- HUMA $5,405.72
- P/E Ratio
- BASE N/A
- HUMA N/A
- Revenue Growth
- BASE 21.00
- HUMA N/A
- 52 Week Low
- BASE $13.53
- HUMA $2.43
- 52 Week High
- BASE $32.00
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- BASE 69.59
- HUMA 40.76
- Support Level
- BASE $15.65
- HUMA $4.75
- Resistance Level
- BASE $20.11
- HUMA $6.11
- Average True Range (ATR)
- BASE 0.60
- HUMA 0.40
- MACD
- BASE 0.26
- HUMA -0.04
- Stochastic Oscillator
- BASE 80.74
- HUMA 6.25
About BASE Couchbase Inc.
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.